{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:08Z","timestamp":1786120388809,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,1]]},"DOI":"10.1097\/qai.0b013e3182515730","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T19:49:24Z","timestamp":1331063364000},"page":"225-233","source":"Crossref","is-referenced-by-count":36,"title":["Low-Frequency Nevirapine Resistance at Multiple Sites May Predict Treatment Failure in Infants on Nevirapine-Based Treatment"],"prefix":"10.1097","volume":"60","author":[{"given":"Dara A.","family":"Lehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton C.","family":"Wamalwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor O.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Matsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Langat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna H.","family":"Chohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Benki-Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Custers-Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic D.","family":"Bushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace C.","family":"John-Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Overbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(99)80008-7","article-title":". Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.","volume":"354","author":"Guay","year":"1999","journal-title":"Lancet"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa033500","article-title":". Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.","volume":"351","author":"Lallemant","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)14341-3","article-title":". Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.","volume":"362","author":"Jackson","year":"2003","journal-title":"Lancet"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/COH.0b013e328333b8ab","article-title":"Use of antiretrovirals during pregnancy and breastfeeding in low-income and middle-income countries.","volume":"5","author":"McIntyre","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"F111","DOI":"10.1097\/00002030-200007280-00001","article-title":". Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.","volume":"14","author":"Jackson","year":"2000","journal-title":"AIDS"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/00002030-200110190-00006","article-title":". Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).","volume":"15","author":"Eshleman","year":"2001","journal-title":"AIDS"},{"key":"R8-3-20210131","first-page":"59","article-title":"Nevirapine resistance after single dose prophylaxis.","volume":"4","author":"Eshleman","year":"2002","journal-title":"AIDS Rev"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/430741","article-title":". Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.","volume":"192","author":"Johnson","year":"2005","journal-title":"J Infect Dis"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1000931","article-title":". Antiretroviral treatment for children with peripartum nevirapine exposure.","volume":"363","author":"Palumbo","year":"2010","journal-title":"N Engl J Med"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa062876","article-title":". Response to antiretroviral therapy after a single, peripartum dose of nevirapine.","volume":"356","author":"Lockman","year":"2007","journal-title":"N Engl J Med"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/511433","article-title":". Persistence of K103N-Containing HIV-1 Variants after Single-Dose Nevirapine for Prevention of HIV-1 Mother-to-Child Transmission.","volume":"195","author":"Flys Tamara","year":"2007","journal-title":"J Infect Dis"},{"key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1086\/430742","article-title":". Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.","volume":"192","author":"Flys","year":"2005","journal-title":"J Infect Dis"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.2010.1278","article-title":". Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.","volume":"304","author":"Coovadia","year":"2010","journal-title":"JAMA"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2011.375","article-title":". Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.","volume":"305","author":"Li","year":"2011","journal-title":"JAMA"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/655397","article-title":"Minority variants of drug-resistant HIV.","volume":"202","author":"Gianella","year":"2010","journal-title":"J Infect Dis"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.1105688108","article-title":". Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine.","volume":"108","author":"Boltz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":". Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.","volume":"364","author":"Newell","year":"2004","journal-title":"Lancet"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1128\/JVI.77.12.7120-7123.2003","article-title":". Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection.","volume":"77","author":"Richardson","year":"2003","journal-title":"J Virol"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00002030-199903110-00006","article-title":". A phase III study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).","volume":"13","author":"Musoke","year":"1999","journal-title":"AIDS"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcv.2010.03.017","article-title":". Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART.","volume":"48","author":"Macleod","year":"2010","journal-title":"J Clin Virol"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/QAD.0b013e3283492180","article-title":". HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine.","volume":"25","author":"Hunt","year":"2011","journal-title":"AIDS"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2431-11-18","article-title":". Evaluation of a single round polymerase chain reaction assay using dried blood spots for diagnosis of HIV-1 infection in infants in an African setting.","volume":"11","author":"Chohan","year":"2011","journal-title":"BMC Pediatr"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/JCM.38.7.2688-2695.2000","article-title":". Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.","volume":"38","author":"Emery","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/QAI.0b013e3181aa8a22","article-title":". Lower risk of resistance after short-course HAART compared to zidovudinesingle-dose nevirapine used for prevention of HIV-1 mother-to-child transmission.","volume":"51","author":"Lehman","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"e11345","DOI":"10.1371\/journal.pone.0011345","article-title":". Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing.","volume":"5","author":"Hedskog","year":"2010","journal-title":"PLoS ONE"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1128\/JCM.01512-06","article-title":". MultiCode-RTx real-time PCR system for detection of subpopulations of K65R human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samples.","volume":"44","author":"Svarovskaia","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1128\/JVI.73.7.5255-5264.1999","article-title":"Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.","volume":"73","author":"Poss","year":"1999","journal-title":"J Virol"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","article-title":"EMBOSS: The European Molecular Biology Software Suite.","volume":"16","author":"Rice","year":"2000","journal-title":"Trends Genet"},{"key":"R32-3-20210131","doi-asserted-by":"crossref","first-page":"e4096","DOI":"10.1371\/journal.pone.0004096","article-title":". Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.","volume":"4","author":"Moorthy","year":"2009","journal-title":"PLoS ONE"},{"key":"R33-3-20210131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0b013e31802b920e","article-title":". Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine.","volume":"44","author":"Martinson","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-3-20210131","doi-asserted-by":"crossref","first-page":"e21655","DOI":"10.1371\/journal.pone.0021655","article-title":". Minor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failure.","volume":"6","author":"Delobel","year":"2011","journal-title":"PLoS ONE"},{"key":"R35-3-20210131","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa041305","article-title":". Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.","volume":"351","author":"Jourdain","year":"2004","journal-title":"N Engl J Med"},{"key":"R36-3-20210131","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.qai.0000174656.71276.d6","article-title":". Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.","volume":"40","author":"Eshleman","year":"2005","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201207010-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:41:31Z","timestamp":1786048891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201207010-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,1]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3182515730","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,1]]}}}